bluebird bio, Inc. (BLUE) - NASDAQ
  • Rod Raynovich | Send Message 21 Apr

    Biotech Recovery Rally: Steady As She Goes-Biogen Rallies On Earnings $BIIB, $BLUE
      • Rod Raynovich | Send Message 13 Apr

        Rayno Biopharmaceuticals 2016 Update: 4/14 All In The Green! $BLUE, $XBI
          • Alexander Valtsev | Send Message 11 Apr

            Goldman Is Buying: Bluebird Bio Off To 'Flying Start'. Read here: $BLUE
              • Alexander Valtsev | Send Message 6 Apr

                Biotech Analysts See Catalysts for Intercept Pharmaceuticals Inc ($ICPT) and Bluebird Bio Inc ($BLUE):
                  • Rod Raynovich | Send Message 31 Mar

                    Rayno Biopharmaceuticals Update 3/30-Stuck In A Trading Range With Upside Opportunities $BLUE, $XBI
                      • Colin Macleod | Send Message 22 Mar

                        Stock Markets Steady After Attack In Brussels $SPY $FB $GILD $IBB $VRX $JUNO $KITE $BLUE $AAPL $TSLA $JPM
                          • Robert A. Desmond | Send Message 19 Mar

                            {video} Best Stock Charts $UGAZ $NFLX $NKE $BPI $DWTI $BLUE $CELG $NM
                              • Michael Blake Kuritz | Send Message 18 Mar

                                sickle cell suckers have killed Accounts $BLUE $AKBA $GBT
                                  • Alexander Valtsev | Send Message 15 Mar

                                    Healthcare Analysts Talk Valeant, Bluebird Bio: $VRX $BLUE
                                      • StockConsultant | Send Message 15 Mar

                                        Bio stocks w/ high trade quality: $BLUE $CLVS $AMAG $CRIS $PBYI $RGLS $RVNS
                                          Company Description
                                          bluebird bio, Inc. is a clinical-stage biotechnology company. The company develops next generation products based on the transformative potential of gene therapy to treat patients with severe genetic and orphan diseases. It has two clinical-stage programs in development for childhood cerebral... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States